Stay updated on Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial
Sign up to get notified when there's something new on the Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial page.

Latest updates to the Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record for the post-marketing surveillance study of Sovaldi plus Copegus in Japanese patients with genotype 2 hepatitis C is displayed, with its study details and locations.SummaryDifference46%

- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with updates and FAQs available.SummaryDifference1%

- Check31 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details, with the standard site header and footer visible, indicating restricted access.SummaryDifference14%

Stay in the know with updates to Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial page.